MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/antibiotics14101008

Медицинская библиотека · Antibiotics (Basel, Switzerland) · 2025

Cerebrospinal Pharmacokinetic Modeling and Pharmacodynamic Simulation of High-Dose Cefazolin for Meningitis Caused by Methicillin-Susceptible Staphylococcus aureus.

Onita Tetsushu, Ikawa Kazuro, Ishihara Noriyuki, Tamaki Hiroki, Yano Takahisa

СтатьяПеревод пока не подготовлен

Аннотация

Background

Cefazolin is being increasingly used to treat central nervous system infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) to mitigate the side effects of existing anti-Staphylococcal drugs. This study aims to develop a cerebrospinal pharmacokinetic (PK) model to predict the cefazolin concentration in cerebrospinal fluid (CSF) and to individualize the dosing regimen for MSSA meningitis.

Methods

A cerebrospinal PK model was developed based on the existing literature and used to estimate the probability of attaining PK/ pharmacodynamic (PD) targets. These targets were set as 100% time above the minimum inhibitory concentration (T > MIC) in CSF. The cerebrospinal PK/PD breakpoint was defined as the highest MIC at which target attainment probability in CSF was ≥90%. The mean CSF/serum ratio estimated from the literature was 0.0525 after a dose of 1-3 g (sampling time: 1-9 h after dose) in adult patients with suspected meningitis. This ratio was incorporated into this PK model based on a hybrid approach.

Results

For patients with creatinine clearance (CLcr) = 90 mL/min, the cerebrospinal PK/PD breakpoint MICs of continuous infusion regimens (6-12 g/day) reached 0.5 µg/mL, which can inhibit the growth of 90% of the MSSA population (MIC90). Furthermore, for patients with renal dysfunction (CLcr = 30 mL/min), a dose reduction (4 g/day) may be required to avoid excessive drug exposure.

Conclusions

High-dose continuous infusion of cefazolin may be appropriate for MSSA meningitis in patients with normal renal function, while dose adjustments are needed for those with renal impairment.

Для цитирования: Onita Tetsushu, Ikawa Kazuro, Ishihara Noriyuki, Tamaki Hiroki, Yano Takahisa. Cerebrospinal Pharmacokinetic Modeling and Pharmacodynamic Simulation of High-Dose Cefazolin for Meningitis Caused by Methicillin-Susceptible Staphylococcus aureus.. Antibiotics (Basel, Switzerland). 2025. DOI: 10.3390/antibiotics14101008.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.